Cargando…

Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017

BACKGROUND: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. METHODS: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukasheva, Gulbarshyn, Abenova, Madina, Shaltynov, Askhat, Tsigengage, Oxana, Mussabekova, Zhanna, Bulegenov, Tolkyn, Shalgumbaeva, Gulnara, Semenova, Yuliya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288408/
https://www.ncbi.nlm.nih.gov/pubmed/35936532
http://dx.doi.org/10.18502/ijph.v51i4.9243
_version_ 1784748467820691456
author Mukasheva, Gulbarshyn
Abenova, Madina
Shaltynov, Askhat
Tsigengage, Oxana
Mussabekova, Zhanna
Bulegenov, Tolkyn
Shalgumbaeva, Gulnara
Semenova, Yuliya
author_facet Mukasheva, Gulbarshyn
Abenova, Madina
Shaltynov, Askhat
Tsigengage, Oxana
Mussabekova, Zhanna
Bulegenov, Tolkyn
Shalgumbaeva, Gulnara
Semenova, Yuliya
author_sort Mukasheva, Gulbarshyn
collection PubMed
description BACKGROUND: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. METHODS: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed based on the annual population statistics. RESULTS: There was an increase in the incidence of cardiovascular disease among the population of Kazakhstan from 1845.4 per 100,000 in 2004 to 2597.5 per 100,000 in 2017. This might be attributed to the implementation of the national health programs, which improved early CVD identification. Incidence of ischemic heart disease (IHD) was grown almost in all provinces of Kazakhstan during the study period. The mortality from cardiovascular disease had a considerable decline over the study period, in particular after 2010, it might be influenced by early diagnosis and provision of timely treatment. CONCLUSION: The experience of Kazakhstan national health programs shows improved identification of CVD and IHD and timely treatment for cardiovascular disease. A significant variation in incidence and mortality rates of cardiovascular disease was observed between the country provinces.
format Online
Article
Text
id pubmed-9288408
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-92884082022-08-04 Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017 Mukasheva, Gulbarshyn Abenova, Madina Shaltynov, Askhat Tsigengage, Oxana Mussabekova, Zhanna Bulegenov, Tolkyn Shalgumbaeva, Gulnara Semenova, Yuliya Iran J Public Health Original Article BACKGROUND: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. METHODS: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from “Medinform” company were analyzed based on the annual population statistics. RESULTS: There was an increase in the incidence of cardiovascular disease among the population of Kazakhstan from 1845.4 per 100,000 in 2004 to 2597.5 per 100,000 in 2017. This might be attributed to the implementation of the national health programs, which improved early CVD identification. Incidence of ischemic heart disease (IHD) was grown almost in all provinces of Kazakhstan during the study period. The mortality from cardiovascular disease had a considerable decline over the study period, in particular after 2010, it might be influenced by early diagnosis and provision of timely treatment. CONCLUSION: The experience of Kazakhstan national health programs shows improved identification of CVD and IHD and timely treatment for cardiovascular disease. A significant variation in incidence and mortality rates of cardiovascular disease was observed between the country provinces. Tehran University of Medical Sciences 2022-04 /pmc/articles/PMC9288408/ /pubmed/35936532 http://dx.doi.org/10.18502/ijph.v51i4.9243 Text en Copyright © 2022 Mukasheva et al. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Mukasheva, Gulbarshyn
Abenova, Madina
Shaltynov, Askhat
Tsigengage, Oxana
Mussabekova, Zhanna
Bulegenov, Tolkyn
Shalgumbaeva, Gulnara
Semenova, Yuliya
Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
title Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
title_full Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
title_fullStr Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
title_full_unstemmed Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
title_short Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004–2017
title_sort incidence and mortality of cardiovascular disease in the republic of kazakhstan: 2004–2017
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288408/
https://www.ncbi.nlm.nih.gov/pubmed/35936532
http://dx.doi.org/10.18502/ijph.v51i4.9243
work_keys_str_mv AT mukashevagulbarshyn incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT abenovamadina incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT shaltynovaskhat incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT tsigengageoxana incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT mussabekovazhanna incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT bulegenovtolkyn incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT shalgumbaevagulnara incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017
AT semenovayuliya incidenceandmortalityofcardiovasculardiseaseintherepublicofkazakhstan20042017